GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (FRA:CHY) » Definitions » Institutional Ownership

ChemoMetec AS (FRA:CHY) Institutional Ownership : 45.15% (As of Apr. 15, 2025)


View and export this data going back to 2019. Start your Free Trial

What is ChemoMetec AS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ChemoMetec AS's institutional ownership is 45.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ChemoMetec AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ChemoMetec AS's Float Percentage Of Total Shares Outstanding is 0.00%.


ChemoMetec AS Institutional Ownership Historical Data

The historical data trend for ChemoMetec AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS Institutional Ownership Chart

ChemoMetec AS Historical Data

The historical data trend for ChemoMetec AS can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 43.71 44.22 42.12 42.65 43.99 43.83 45.39 44.85 45.31 45.15

ChemoMetec AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


ChemoMetec AS Business Description

Traded in Other Exchanges
Address
Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.